A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and ...

Elon Musk and his Department of Government Efficiency (DOGE) team created the new org chart for HHS, said Robert F. Kennedy ...

As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and ...

The ruling makes clear that the FDA lacks the legal authority to regulate LDTs, and observers suggest it could also call into question its authority in other areas.

RAD52 has already shown promise as a drug target. Inhibitors of the protein can selectively kill cancerous cells while ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

"This new structure provides clues about which important areas of the protein can be targeted for future drug discovery." Spies's team already has small molecules that bind and inhibit RAD52 ...

As with its predecessor, the new drug candidate, Jun13296, targets a different viral protein than Paxlovid does and works alone rather than in combination with another drug called ritonavir. But ...

The HHS secretary said when he arrived at the department, the org chart was "incomprehensible ... Scores of divisions at NIH, FDA, and CDC lost workers, though the true extent of the firings ...

Mandimycin, which targets a different essential fungi cell resource than other antifungal drugs, should harm other cell types as collateral — but doesn’t.